These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 36055737)

  • 21. Understanding the Health Needs and Priorities of People Who Access Comprehensive Harm Reduction Programs.
    Chhabra M; Stavas N; Vij N; Kumar E; Shea JA
    J Health Care Poor Underserved; 2020; 31(4):1747-1764. PubMed ID: 33416750
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Peer-delivered harm reduction and recovery support services: initial evaluation from a hybrid recovery community drop-in center and syringe exchange program.
    Ashford RD; Curtis B; Brown AM
    Harm Reduct J; 2018 Oct; 15(1):52. PubMed ID: 30348170
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Monitoring and tackling smoking and other addictions: Current situation and perspectives].
    Beck F; Lermenier-Jeannet A; Nguyen-Thanh V
    Bull Cancer; 2019; 106(7-8):656-664. PubMed ID: 30616838
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrative harm reduction psychotherapy: a case of substance use, multiple trauma, and suicidality.
    Tatarsky A; Kellogg S
    J Clin Psychol; 2010 Feb; 66(2):123-35. PubMed ID: 20088005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A systematic review of the effectiveness of digital interventions for illicit substance misuse harm reduction in third-level students.
    Dick S; Whelan E; Davoren MP; Dockray S; Heavin C; Linehan C; Byrne M
    BMC Public Health; 2019 Sep; 19(1):1244. PubMed ID: 31500618
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Problematic substance use or problematic substance use policies?
    Stockwell T; Benoit C; Card K; Sherk A
    Health Promot Chronic Dis Prev Can; 2020 Jun; 40(5-6):135-142. PubMed ID: 32529972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How the harm reduction movement contrasts itself against punitive prohibition.
    Tammi T; Hurme T
    Int J Drug Policy; 2007 Mar; 18(2):84-7. PubMed ID: 17689349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advocating for a harm-minimization approach to drug education in Australian schools.
    Guzys D; Kendall S
    J Sch Nurs; 2006 Oct; 22(5):259-63. PubMed ID: 17172197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrating harm reduction therapy and traditional substance abuse treatment.
    Marlatt GA; Blume AW; Parks GA
    J Psychoactive Drugs; 2001; 33(1):13-21. PubMed ID: 11332996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contested space in the pharmacy: public attitudes to pharmacy harm reduction services in the West of Scotland.
    Gidman W; Coomber R
    Res Social Adm Pharm; 2014; 10(3):576-87. PubMed ID: 24021859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Harm Reduction Services to Prevent and Treat Infectious Diseases in People Who Use Drugs.
    Thakarar K; Nenninger K; Agmas W
    Infect Dis Clin North Am; 2020 Sep; 34(3):605-620. PubMed ID: 32782104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Managed alcohol as a harm reduction intervention for alcohol addiction in populations at high risk for substance abuse.
    Muckle W; Muckle J; Welch V; Tugwell P
    Cochrane Database Syst Rev; 2012 Dec; 12():CD006747. PubMed ID: 23235633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Harm reduction interventions in drug users: current situation and recommendations].
    Bosque-Prous M; Brugal MT
    Gac Sanit; 2016 Nov; 30 Suppl 1():99-105. PubMed ID: 27837802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluating mobile harm reduction services for youth and young adults.
    Yeo EJ; Hausman E; Noyes E; Chatterjee A
    Front Public Health; 2024; 12():1375323. PubMed ID: 38841665
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Harm Reduction in Health Care Settings.
    Chan CA; Canver B; McNeil R; Sue KL
    Med Clin North Am; 2022 Jan; 106(1):201-217. PubMed ID: 34823731
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assembling the dominant accounts of youth drug use in Australian harm reduction drug education.
    Farrugia A
    Int J Drug Policy; 2014 Jul; 25(4):663-72. PubMed ID: 24882707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug use treatment and harm reduction programs in Iran: A unique model of health in the most populated Persian Gulf country.
    Alam-Mehrjerdi Z; Abdollahi M; Higgs P; Dolan K
    Asian J Psychiatr; 2015 Aug; 16():78-83. PubMed ID: 26168763
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Principles of Harm Reduction for Young People Who Use Drugs.
    Kimmel SD; Gaeta JM; Hadland SE; Hallett E; Marshall BDL
    Pediatrics; 2021 Jan; 147(Suppl 2):S240-S248. PubMed ID: 33386326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Public Health and the origins of the Mersey Model of Harm Reduction.
    Ashton JR; Seymour H
    Int J Drug Policy; 2010 Mar; 21(2):94-6. PubMed ID: 20163946
    [TBL] [Abstract][Full Text] [Related]  

  • 40. State of the art in harm reduction psychotherapy: an emerging treatment for substance misuse.
    Tatarsky A; Marlatt GA
    J Clin Psychol; 2010 Feb; 66(2):117-22. PubMed ID: 20049922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.